Inhibition of PDGF receptor signaling sensitizes cells to anti-VEGF/VEGFR treatment, suggesting a possible route of resistance and a potential therapeutic target in anti-VEGFR melanoma therapy [181]. The gene discussed is VEGFA; the disease is melanoma.